Mycophenolate pregnancy registry for mothers in the U.S.
Part of Immune system & allergy clinical trials.
This study collects information about pregnancies where a mother took mycophenolate during pregnancy (or stopped within the prior 6 weeks). It aims to better understand pregnancy outcomes and risks so care can be improved for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant, or you are reporting a recent pregnancy
- You took mycophenolate during pregnancy, or you stopped it within the last 6 weeks
- The exposure came from the mother (not only from the father)
- The pregnancy occurred in the United States
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps track how psychiatric (mental health) medicines affect pregnancy outcomes by collecting phone interviews during pregnancy. If you are pregnant and take (or have taken) mental health medication, you may help doctors understand risks and benefits better.
This trial checks how well the drug mycophenolate mofetil works in people with lupus kidney disease by measuring drug levels in the blood. It aims to help doctors adjust doses for better control of the disease.
This trial tests a mycophenolate-based therapy for kidney transplant recipients who have no HLA-DQ mismatch. If you had your first kidney transplant 3-12 months ago without DQ mismatch and are on standard immunosuppressants, you may qualify.
This trial tests whether giving mycophenolate (a drug that calms the immune system) after a stem cell transplant helps people with systemic sclerosis (scleroderma) have better long-term outcomes. It may help prevent the disease from coming back or getting worse.
This study tracks the health of women with kidney problems before, during, and after pregnancy to learn how to better care for them. It is for women who have had kidney disease, high blood pressure, certain pregnancy complications, or a kidney transplant.
This trial tests a combination of two drugs, mycophenolate mofetil and prednisone, to treat moderate to severe liver inflammation caused by immunotherapy. The goal is to see if this treatment can help control the inflammation without needing long-term high-dose steroids.
Hear when a new Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.